SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH M impact

FT: Johnson & Johnson Looking to Buy Ollin Biosciences for Up to $3.4 Billion

The Financial Times reports that Johnson & Johnson is looking to buy eye-disease biotech Ollin Biosciences for up to $3.4 billion.

JNJ

Related stories